Citation: Rf. Robinson et Mc. Nahata, Safety of intravenous bolus administration of gentamicin in pediatric patients, ANN PHARMAC, 35(11), 2001, pp. 1327-1331
Citation: Rf. Robinson et Mc. Nahata, Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection, AM J HEAL S, 57(3), 2000, pp. 259-264
Citation: Mc. Nahata et al., Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 degrees C, AM J HEAL S, 57(12), 2000, pp. 1141-1143
Citation: Vb. Pai et Mc. Nahata, Aerosolized furosemide in the treatment of acute respiratory distress and possible bronchopulmonary dysplasia in preterm neonates, ANN PHARMAC, 34(3), 2000, pp. 386-392
Citation: Vb. Pai et al., Acute hepatitis and bleeding possibly induced by zidovudine and ritonavir in an infant with HIV infection, PHARMACOTHE, 20(9), 2000, pp. 1135-1140
Citation: Vb. Pai et Mc. Nahata, Duration of penicillin prophylaxis in sickle cell anemia: Issues and controversies, PHARMACOTHE, 20(1), 2000, pp. 110-117
Citation: Mc. Nahata et al., Development of two stable oral suspensions of levodopa-carbidopa for children with amblyopia, J PEDIAT OP, 37(6), 2000, pp. 333-337
Citation: Vb. Pai et Mc. Nahata, Cardiotoxicity of chemotherapeutic agents - Incidence, treatment and prevention, DRUG SAFETY, 22(4), 2000, pp. 263-302